The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses (Q24645843)
scientific article
Language:
(P31) (Q13442814)
(P304) 6147-57
(P407) (Q1860)
(P433) 12
(P478) 164
(P577) Thursday, June 15, 2000
(P921) (Q5383826)
(P1433) (Q3521441)
(P1476) "The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses" (language: en)
(P2093) K Schwarz
R de Giuli
G Schmidtke
S Kostka
M van den Broek
K B Kim
C M Crews
R Kraft
M Groettrup
(P2860) (Q24679238)
(Q22001460)
(Q24671114)
(Q27735081)
(Q27939678)
(Q28198607)
(Q28248180)
(Q28300614)
(Q28317856)
(Q29619692)
(Q33882609)
(Q40940981)
(Q33652524)
(Q36368140)
(Q36638199)
(Q41027912)
(Q41029842)
(Q36400848)
(Q41034976)
(Q41043791)
(Q41099571)
(Q41109895)
(Q41149916)
(Q34392468)
(Q36355512)
(Q40067052)
(Q41187633)
(Q41283840)
(Q41690263)
(Q46965612)
(Q44031720)
(Q45795025)
(Q42013352)
(Q41681194)
(Q41671793)
(Q52174827)
(Q42971836)
(Q52060747)
(Q74525491)
(Q73398664)
(Q77420527)
(Q73566977)
(Q77584365)
(Q73075592)
(Q73648068)
(Q67541704)
(Q67914016)
(Q59167181)
(Q70916536)
(Q63533307)
other details